Zhende Medical Co., Ltd. (603301.SS)
CNY 20.87
(0.72%)
CNY 20.87
(0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.43 Billion CNY | -33.26% |
| 2022 | 2.14 Billion CNY | 21.08% |
| 2021 | 1.77 Billion CNY | -63.71% |
| 2020 | 4.88 Billion CNY | 715.46% |
| 2019 | 598.9 Million CNY | 33.65% |
| 2018 | 448.12 Million CNY | 15.93% |
| 2017 | 386.53 Million CNY | 17.84% |
| 2016 | 328.01 Million CNY | 7.46% |
| 2015 | 305.25 Million CNY | 39.67% |
| 2014 | 218.54 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 356.72 Million CNY | 6.13% |
| 2024 Q1 | 335.72 Million CNY | 1.58% |
| 2024 Q2 | 344.61 Million CNY | 2.65% |
| 2023 Q3 | 300.88 Million CNY | -10.98% |
| 2023 FY | 1.43 Billion CNY | -33.26% |
| 2023 Q1 | 463.01 Million CNY | -38.52% |
| 2023 Q2 | 338.01 Million CNY | -27.0% |
| 2023 Q4 | 330.51 Million CNY | 9.85% |
| 2022 FY | 2.14 Billion CNY | 21.08% |
| 2022 Q3 | 472.05 Million CNY | -7.06% |
| 2022 Q4 | 753.08 Million CNY | 59.53% |
| 2022 Q2 | 507.93 Million CNY | 22.97% |
| 2022 Q1 | 413.05 Million CNY | -2.36% |
| 2021 FY | 1.77 Billion CNY | -63.71% |
| 2021 Q3 | 318.72 Million CNY | 14.21% |
| 2021 Q4 | 423.04 Million CNY | 32.73% |
| 2021 Q1 | 751.58 Million CNY | -32.43% |
| 2021 Q2 | 279.07 Million CNY | -62.87% |
| 2020 Q4 | 1.11 Billion CNY | -44.94% |
| 2020 FY | 4.88 Billion CNY | 715.46% |
| 2020 Q1 | 298.4 Million CNY | 57.71% |
| 2020 Q2 | 1.45 Billion CNY | 386.87% |
| 2020 Q3 | 2.02 Billion CNY | 39.05% |
| 2019 FY | 598.9 Million CNY | 33.65% |
| 2019 Q4 | 189.21 Million CNY | 7.72% |
| 2019 Q3 | 175.65 Million CNY | 28.21% |
| 2019 Q2 | 137 Million CNY | 41.2% |
| 2019 Q1 | 97.03 Million CNY | -29.64% |
| 2018 Q4 | 137.9 Million CNY | 13.73% |
| 2018 FY | 448.12 Million CNY | 15.93% |
| 2018 Q1 | 79.95 Million CNY | -27.47% |
| 2018 Q2 | 109 Million CNY | 36.32% |
| 2018 Q3 | 121.26 Million CNY | 11.25% |
| 2017 Q2 | 99.65 Million CNY | 22.93% |
| 2017 Q1 | 81.06 Million CNY | 0.0% |
| 2017 FY | 386.53 Million CNY | 17.84% |
| 2017 Q3 | 95.57 Million CNY | -4.09% |
| 2017 Q4 | 110.24 Million CNY | 15.35% |
| 2016 FY | 328.01 Million CNY | 7.46% |
| 2015 FY | 305.25 Million CNY | 39.67% |
| 2014 FY | 218.54 Million CNY | 0.0% |